In vivo evidence of glutamate toxicity in multiple sclerosis-Reference-Cited by-同舟云学术

In vivo evidence of glutamate toxicity in multiple sclerosis

Published:2014-07-09 Issue:2 Volume:76 Page:269-278
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Azevedo Christina J.¹^ORCID,Kornak John²,Chu Philip³,Sampat Mehul¹,Okuda Darin T.⁴,Cree Bruce A.⁵,Nelson Sarah J.⁶,Hauser Stephen L.⁵,Pelletier Daniel¹

Affiliation:

1. Department of Neurology; Yale University; New Haven CT

2. Department of Epidemiology and Biostatistics; University of California; San Francisco San Francisco, CA

3. Department of Medicine; University of California; San Francisco San Francisco, CA

4. Department of Neurology; University of Texas Southwestern; Dallas TX

5. Department of Neurology; University of California; San Francisco San Francisco, CA

6. Department of Radiology; University of California; San Francisco San Francisco, CA

Funder

Biogen-Idec

GlaxoSmithKline

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference43 articles.

1. Glutamate-mediated glial injury: mechanisms and clinical importance;Matute;Glia,2006

2. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage;Werner;Ann Neurol,2001

3. Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis;Pitt;Neurology,2003

4. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis;Geurts;Brain,2003

5. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid;Sarchielli;Arch Neurol,2003

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamate Chemical Exchange Saturation Transfer (GluCEST) MRI to evaluate the relationship between demyelination and glutamate content in depressed mice;Behavioural Brain Research;2024-09

2. Association of Cortical Lesions With Regional Glutamate, GABA, N -Acetylaspartate, and Myoinositol Levels in Patients With Multiple Sclerosis;Neurology;2024-07

3. Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis;Frontiers in Immunology;2024-06-07

4. Sub-clinical glutamate receptor antagonist combinations prevent progressive demyelination;2024-03-20

5. MicroRNA-92a–CPEB3 axis protects neurons against inflammatory neurodegeneration;Science Advances;2023-11-24